Identification of potent histone deacetylase 2 (HDAC2) inhibitors through combined structure and ligand-based designs and molecular modelling approach
- 12 June 2023
- journal article
- research article
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 42 (9) , 4679-4698
Abstract
Histone deacetylase 2 (HDAC2) is associated with various neuropathic degenerative diseases and is considered a novel target for Alzheimer's disease (AD). Elevated levels of HDAC2 trigger excitatory neurotransmission and reduce synaptic plasticity, synaptic number, and memory formation. In the current study, we identified HDAC2 inhibitors using an integrated structure and ligand-based approaches to drug design. Three pharmacophore models were generated by using different pharmacophoric features and validated using the Enrichment factor (EF), Guner-henry (GH) score, and percentage yield. The model of choice was used to screen a library of Zinc-15 compounds and interfering compounds were eliminated by using drug likeliness and PAINS filtering. Further, docking studies in three stages were carried out to obtain hits with good binding energies and were followed by ADMET studies yielding three virtual hits. The virtual hits, i.e. ZINC000008184553, ZINC0000013641114, and ZINC000032533141, were subjected to molecular dynamics simulation studies. Compound ZINC000008184553, identified as lead, was found to have optimal stability, low toxicity under simulated conditions, and may potentially inhibit HDAC2.Communicated by Ramaswamy H. SarmaKeywords
This publication has 50 references indexed in Scilit:
- Oligomers of beta-amyloid protein (Aβ1-42) induce the activation of cyclooxygenase-2 in astrocytes via an interaction with interleukin-1beta, tumour necrosis factor-alpha, and a nuclear factor kappa-B mechanism in the rat brainExperimental Neurology, 2012
- An epigenetic blockade of cognitive functions in the neurodegenerating brainNature, 2012
- AMP‐activated protein kinase: a potential player in Alzheimer’s diseaseJournal of Neurochemistry, 2011
- Acetylation of Tau Inhibits Its Degradation and Contributes to TauopathyNeuron, 2010
- A sorting optimization curve with quality and yield requirementsPattern Recognition Letters, 2010
- Histone Deacetylases 1 and 2 Form a Developmental Switch That Controls Excitatory Synapse Maturation and FunctionThe Journal of Neuroscience, 2009
- HDAC2 negatively regulates memory formation and synaptic plasticityNature, 2009
- The many roles of histone deacetylases in development and physiology: implications for disease and therapyNature Reviews Genetics, 2009
- HDAC2 deficiency sensitizes colon cancer cells to TNFα-induced apoptosis through inhibition of NF-κB activityExperimental Cell Research, 2008
- Homo-oligomerisation and nuclear localisation of mouse histone deacetylase 111Edited by J. KarnJournal of Molecular Biology, 2001